| pubmed-article:10807467 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10807467 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:10807467 | lifeskim:mentions | umls-concept:C0332835 | lld:lifeskim |
| pubmed-article:10807467 | lifeskim:mentions | umls-concept:C0232338 | lld:lifeskim |
| pubmed-article:10807467 | lifeskim:mentions | umls-concept:C1522318 | lld:lifeskim |
| pubmed-article:10807467 | lifeskim:mentions | umls-concept:C0006100 | lld:lifeskim |
| pubmed-article:10807467 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:10807467 | lifeskim:mentions | umls-concept:C0597640 | lld:lifeskim |
| pubmed-article:10807467 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:10807467 | pubmed:dateCreated | 2000-5-18 | lld:pubmed |
| pubmed-article:10807467 | pubmed:abstractText | To evaluate the effects of exogenous bradykinin on coronary epicardial and microcirculatory tone in transplant patients (HTXs), and to compare them with the effects of acetylcholine. | lld:pubmed |
| pubmed-article:10807467 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10807467 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10807467 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10807467 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:10807467 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10807467 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10807467 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10807467 | pubmed:month | May | lld:pubmed |
| pubmed-article:10807467 | pubmed:issn | 0735-1097 | lld:pubmed |
| pubmed-article:10807467 | pubmed:author | pubmed-author:LoisanceDD | lld:pubmed |
| pubmed-article:10807467 | pubmed:author | pubmed-author:CastaigneAA | lld:pubmed |
| pubmed-article:10807467 | pubmed:author | pubmed-author:BenvenutiCC | lld:pubmed |
| pubmed-article:10807467 | pubmed:author | pubmed-author:KernM JMJ | lld:pubmed |
| pubmed-article:10807467 | pubmed:author | pubmed-author:Dubois-RandéJ... | lld:pubmed |
| pubmed-article:10807467 | pubmed:author | pubmed-author:TeigenAA | lld:pubmed |
| pubmed-article:10807467 | pubmed:author | pubmed-author:SediameSS | lld:pubmed |
| pubmed-article:10807467 | pubmed:author | pubmed-author:AptecarEE | lld:pubmed |
| pubmed-article:10807467 | pubmed:author | pubmed-author:PernesJ MJM | lld:pubmed |
| pubmed-article:10807467 | pubmed:author | pubmed-author:DupouyPP | lld:pubmed |
| pubmed-article:10807467 | pubmed:author | pubmed-author:WoscoboinikJJ | lld:pubmed |
| pubmed-article:10807467 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10807467 | pubmed:volume | 35 | lld:pubmed |
| pubmed-article:10807467 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10807467 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10807467 | pubmed:pagination | 1607-15 | lld:pubmed |
| pubmed-article:10807467 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:10807467 | pubmed:meshHeading | pubmed-meshheading:10807467... | lld:pubmed |
| pubmed-article:10807467 | pubmed:meshHeading | pubmed-meshheading:10807467... | lld:pubmed |
| pubmed-article:10807467 | pubmed:meshHeading | pubmed-meshheading:10807467... | lld:pubmed |
| pubmed-article:10807467 | pubmed:meshHeading | pubmed-meshheading:10807467... | lld:pubmed |
| pubmed-article:10807467 | pubmed:meshHeading | pubmed-meshheading:10807467... | lld:pubmed |
| pubmed-article:10807467 | pubmed:meshHeading | pubmed-meshheading:10807467... | lld:pubmed |
| pubmed-article:10807467 | pubmed:meshHeading | pubmed-meshheading:10807467... | lld:pubmed |
| pubmed-article:10807467 | pubmed:meshHeading | pubmed-meshheading:10807467... | lld:pubmed |
| pubmed-article:10807467 | pubmed:meshHeading | pubmed-meshheading:10807467... | lld:pubmed |
| pubmed-article:10807467 | pubmed:meshHeading | pubmed-meshheading:10807467... | lld:pubmed |
| pubmed-article:10807467 | pubmed:meshHeading | pubmed-meshheading:10807467... | lld:pubmed |
| pubmed-article:10807467 | pubmed:meshHeading | pubmed-meshheading:10807467... | lld:pubmed |
| pubmed-article:10807467 | pubmed:meshHeading | pubmed-meshheading:10807467... | lld:pubmed |
| pubmed-article:10807467 | pubmed:meshHeading | pubmed-meshheading:10807467... | lld:pubmed |
| pubmed-article:10807467 | pubmed:meshHeading | pubmed-meshheading:10807467... | lld:pubmed |
| pubmed-article:10807467 | pubmed:meshHeading | pubmed-meshheading:10807467... | lld:pubmed |
| pubmed-article:10807467 | pubmed:year | 2000 | lld:pubmed |
| pubmed-article:10807467 | pubmed:articleTitle | Effects of bradykinin on coronary blood flow and vasomotion in transplant patients. | lld:pubmed |
| pubmed-article:10807467 | pubmed:affiliation | Fédération de Cardiologie et Institut National de la Santé et de la Recherche Médicale U400, Créteil, France. eaptecar@club-inernet.fr | lld:pubmed |
| pubmed-article:10807467 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10807467 | lld:pubmed |
